血液透析与腹膜透析治疗终末期糖尿病肾病疗效比较

Efficacy Comparison of Hemodialysis and Peritoneal Dialysis in the Treatment of End-Stage Diabetes Nephropathy

目的比较血液透析与腹膜透析治疗终末期糖尿病肾病的疗效。方法选取医院2019年5月至2022年11月收治的患者62例,按随机数字表法分为对照组和观察组,各31例。对照组患者予常规血液透析治疗,观察组患者予腹膜透析治疗。两组患者均持续透析1年。结果观察组总有效率为93.55%,显著高于对照组的67.74%(P<0.05)。观察组患者的血尿素氮、血肌酐、甲状旁腺激素、血磷水平均显著低于对照组,白蛋白水平显著高于对照组(P<0.05)。观察组并发症发生率显著低于对照组(P<0.05)。结论相比于血液透析,腹膜透析治疗终末期糖尿病肾病,对患者的肾功能指标、临床指标改善更显著,可有效控制并发症,达到预期疗效。

Objective To compare the efficacy of hemodialysis and peritoneal dialysis in the treatment of end-stage diabetes nephropathy.Methods A total of 62 patients with end-stage diabetes nephropathy admitted to the hospital from May 2019 to November 2022 were randomly divided into the control group and the observation group,with 31 cases in each group.The control group received routine hemodialysis treatment,while the observation group received peritoneal dialysis treatment.Both groups underwent continuous dialysis for 1 year.Results The total effective rate in the observation group was 93.55%,which was significantly higher than 67.74%in the control group(P<0.05).The levels of blood urea nitrogen,blood creatinine,parathyroid hormone,and blood phosphorus in the observation group were significantly lower than those in the control group,while the levels of albumin in the observation group was significantly higher than that in the control group(P<0.05).The incidence of complications in the observation group was significantly lower than that in the control group(P<0.05).Conclusion Compared with hemodialysis,peritoneal dialysis in the treatment of end-stage diabetes nephropathy can significantly improve the renal function and clinical indicators of patients,effectively control complications and achieve the desired efficacy.